-PTI The Supreme Court on Monday expressed concern over alleged illegal clinical trial of drugs in the country, saying its "unfortunate" that humans were being treated as "guinea pigs". A bench headed by Justice R M Lodha pulled up the Centre and the Madhya Pradesh government for not filing their response on PILs alleging large-scale illegal Drug Trials in the state and other parts of the country. The bench said, "There has to...

A cure for India’s health care ills is within reach provided there is political will In most developed — and many developing — countries today, a 12-year school education and universal health coverage (UHC) are the two primary responsibilities of the state. India has failed miserably on both counts. Let us look at some of the problems of medical and health care: • Fifty years ago, when there was no commercialisation of...

Tuberculosis re-emerges as a major threat as new drug-resistant strains develop because of mismanagement of the disease. At the beginning of the year, doctors at Mumbai’s P.D. Hinduja National Hospital and Medical Research Centre reported that they had 12 patients infected with TDR-TB, or totally drug-resistant tuberculosis, a condition in which the TB bacilli is resistant to all first- and second-line drugs used in the conventional treatment of the disease. Panic...

-The Economic Times It's not just the drug regulator, where a parliamentary panel has alleged corruption, failing in its job. Drug regulation across entities that dot this broad landscape is in poor health and ineffective. In May, when a Parliamentary panel, during a routine examination of healthcare regulatory bodies, alleged corruption in the approval of new drugs, it was merely pointing out one symptom. Such symptoms pervade the entire drug regulation landscape,...

-The Indian Express India may not be a testing hub for Big Pharma. But informed consent must be non-negotiable Figures released by the World Health Organisation, which show that 10 Indian subjects of clinical field trials die every week, have rekindled concerns that this country has become a testing hub for Big Pharma. Ironically, the same figures deflate this persistent fear, revealing that only 1.5 per cent of global trials have been...